{"id":12365,"date":"2019-02-07T16:35:01","date_gmt":"2019-02-07T16:35:01","guid":{"rendered":"https:\/\/beyondtype2.org\/resources\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/"},"modified":"2019-02-07T16:35:01","modified_gmt":"2019-02-07T16:35:01","slug":"llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/","title":{"rendered":"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza"},"content":{"rendered":"<p>El martes, un grupo de senadores de los Estados Unidos, dirigidos por Patty Murray (D-WA) envi&oacute; cartas a ejecutivos de los &laquo;Tres Grandes&raquo; fabricantes de insulinas &ndash; &nbsp; Eli Lilly, Novo Nordisk, y Sanofi &mdash; exigiendo informaci&oacute;n sobre los costos a la alza de las insulinas en los Estados Unidos.<\/p>\n<p>Una parte de esta carta lee:<\/p>\n<p><i>&ldquo;De acuerdo con la Organizaci&oacute;n Mundial de la Salud, la insulina es un medicamento vital, esto significa que el acceso a este f&aacute;rmaco debe garantizarse a un costo que todos los&nbsp;individuos&nbsp;y las&nbsp;comunidades puedan pagarlo como requerimiento de un sistema de cuidado a la salud funcional. Desafortunadamente, la alza abrupta en los &nbsp;costos &nbsp;significa &nbsp;que para muchos pacientes, el acceso a este medicamento vital para su vida, est&aacute; en riesgo. Los pacientes deben buscar medidas desesperadas al enfrentarse con estos costos. Algunos de ellos han utilizado p&aacute;ginas de recaudaci&oacute;n como &nbsp;GoFundMe pidiendo ayuda para pagar sus insulinas y una de cada cuatro personas con diabetes reportan racionar su insulina por el costo, con el riesgo de desarrollar complicaciones devastadoras. Est&aacute; claro que esta alza en los costos ocasiona que los pacientes no tengan acceso a los medicamentos que podr&iacute;an salvar su vida.&rdquo;<\/i><\/p>\n<p>Ha habido mucha atenci&oacute;n recientemente en la elevaci&oacute;n de costos y vemos cada vez con mayor frecuencia historias sobre racionar el uso de insulina.&nbsp;La noticia aparece junto con varios pol&iacute;ticos prominentes uni&eacute;ndose al debate de costos de insulina.<\/p>\n<p>En Diciembre pasado, el comisionado de la FDAScott Gottlieb, M.D.,&nbsp;<a href=\"https:\/\/beyondtype1.org\/es\/comisionado-de-la-fda-hace-declaracion-sobre-el-precio-de-la-insulina\/\" data-wpel-link=\"internal\">emiti&oacute; una declaraci&oacute;n&nbsp;<\/a>&nbsp;detallando gu&iacute;as dise&ntilde;adas para incrementar la competitividad y reducir los costos en el merado de insulinas. En Enero, un miembro del Congreso present&oacute; la ley&nbsp;<a href=\"https:\/\/beyondtype1.org\/insulin-access-act\/\" data-wpel-link=\"internal\" target=\"_blank\" rel=\"noopener noreferrer\">&ldquo;Acceso a Insulina para Todos<\/a>&nbsp;para los beneficiarios de Medicare y Medicaid beneficiaries. Y el lunes 14 de enero, El Comit&eacute; de Supervisi&oacute;n de la C&aacute;mara anunci&oacute; que est&aacute; investigando acciones de una docena de compa&ntilde;&iacute;as farmac&eacute;uticas. Eli Lilly, Novo Nordisk, y Sanofi se encuentran entre estas compa&ntilde;&iacute;as de las que este comit&eacute; busca informaci&oacute;n detallada sobre el costo de sus medicamentos.<\/p>\n<p>Estas cartas (disponibles abajo) tambi&eacute;n fueron firmadas por los Senadores Bob Casey (D-PA), Maggie Hassan (D-NH), Doug Jones (D-AL), Tim Kaine (D-VA), Chris Murphy (D-CT), Tammy Baldwin (D-WI), Jacky Rosen (D-NV), Bernie Sanders (I-VT), Tina Smith (D-MN) y Elizabeth Warren (D-MA).<\/p>\n<ul>\n<li>PDF de la carta a &nbsp;Eli Lilly&nbsp;<a href=\"https:\/\/www.help.senate.gov\/imo\/media\/doc\/20190205%20Eli%20Lilly%20Insulin%20Pricing%20Letter%20FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-wpel-link=\"external\">AQU&Iacute;<\/a><\/li>\n<li>PDF de la carta a Novo Nordisk &nbsp;<a href=\"https:\/\/www.help.senate.gov\/imo\/media\/doc\/20190205%20Novo%20Nordisk%20Insulin%20Pricing%20Letter%20FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-wpel-link=\"external\">AQU&Iacute;<\/a><\/li>\n<li>PDF de la carta a&nbsp;Sanofi&nbsp;<a href=\"https:\/\/www.help.senate.gov\/imo\/media\/doc\/20190205%20Sanofi%20Insulin%20Pricing%20Letter%20FINAL.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-wpel-link=\"external\">AQU&Iacute;<\/a><\/li>\n<\/ul>\n\n","protected":false},"excerpt":{"rendered":"<p>El martes, un grupo de senadores de los Estados Unidos, dirigidos por Patty Murray (D-WA) envi&oacute; cartas a ejecutivos de los &laquo;Tres Grandes&raquo; fabricantes de insulinas &ndash; &nbsp; Eli Lilly, Novo Nordisk, y Sanofi &mdash; exigiendo informaci&oacute;n sobre los costos a la alza de las insulinas en los Estados Unidos. Una parte de esta carta [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":12367,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-12365","resources","type-resources","status-publish","has-post-thumbnail","hentry","diabetes-types-tipo-1","tags-acceso","tags-insulinnewslearn","tags-noticias","tags-todd-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Llamado a Fabricantes de Insulina para Explicar Costos a la Alza | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"El martes, un grupo de senadores envi\u00f3 cartas fabricantes de insulinas exigiendo informaci\u00f3n sobre los costos a la alza de las insulinas.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"El martes, un grupo de senadores envi\u00f3 cartas fabricantes de insulinas exigiendo informaci\u00f3n sobre los costos a la alza de las insulinas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/\",\"name\":\"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png\",\"datePublished\":\"2019-02-07T16:35:01+00:00\",\"description\":\"El martes, un grupo de senadores envi\u00f3 cartas fabricantes de insulinas exigiendo informaci\u00f3n sobre los costos a la alza de las insulinas.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png\",\"width\":2048,\"height\":733},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza | Beyond Type 1","description":"El martes, un grupo de senadores envi\u00f3 cartas fabricantes de insulinas exigiendo informaci\u00f3n sobre los costos a la alza de las insulinas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/","og_locale":"es_ES","og_type":"article","og_title":"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza | Beyond Type 1","og_description":"El martes, un grupo de senadores envi\u00f3 cartas fabricantes de insulinas exigiendo informaci\u00f3n sobre los costos a la alza de las insulinas.","og_url":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","og_image":[{"width":2048,"height":733,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/","url":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/","name":"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png","datePublished":"2019-02-07T16:35:01+00:00","description":"El martes, un grupo de senadores envi\u00f3 cartas fabricantes de insulinas exigiendo informaci\u00f3n sobre los costos a la alza de las insulinas.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-HEADER-INSULIN-SKYROCKETING.png","width":2048,"height":733},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/llamado-a-fabricantes-de-insulina-para-explicar-costos-a-la-alza\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"Llamado a Fabricantes de Insulina para Explicar Costos a la Alza"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/12365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=12365"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/12365\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/12367"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=12365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}